Validation of Prediction of Diabetes by Archimedes and Comparison with Other Predicting Models
- Michael Stern, MD1,
- Ken Williams, MS2,
- David Eddy, MD, PhD3 and
- Richard Kahn, PhD (rkahn{at}diabetes.org)4
- 1Division of Clinical Epidemiology, University of Texas Health Science Center, San Antonio, TX
- 2KenAnCo Biostatistics, San Antonio TX
- 3Archimedes, Inc. San Francisco, CA
- 4American Diabetes Association, Alexandria, VA
Abstract
Objective: To validate the ability of the Archimedes Model to accurately predict the risk of developing diabetes in individuals.
Research Design and Methods: Subjects were randomly selected from the San Antonio Heart Study population. The area under the Receiver Operator Characteristic (aROC) curve derived from the Archimedes Model was calculated and also compared to the aROCs from two published multiple logistic regression models designed to estimate diabetes risk.
Results: The aROC ( 95% CI) for the Archimedes Model was 0.818 ( 0.739,0.899) compared to aROCs of 0.869 ( 0.801,0.936) and 0.870 ( 0.802, 0.937) for the two logistic regression models, respectively. Risk estimates from the logistic models were highly correlated with the estimates derived from the Archimedes Model.
Conclusions: The Archimedes Model predicts individual diabetes risk with a high level of sensitivity and specificity, comparable to that of models designed specifically for that purpose. Unlike the latter models, Archimedes also predicts the risk of numerous other health outcomes.
Footnotes
-
- Received March 13, 2008.
- Accepted May 15, 2008.
- Copyright © American Diabetes Association











